As of 2025-12-27, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -16.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 150.59 mil USD. Apyx's TTM EBITDA according to its financial statements is -9.02 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 22.0x | 20.9x |
| Forward P/E multiples | 21.8x - 24.6x | 23.0x |
| Fair Price | (5.02) - (5.06) | (5.05) |
| Upside | -245.8% - -247.1% | -246.9% |
| Date | EV/EBITDA |
| 2025-12-24 | -17.43 |
| 2025-12-23 | -17.43 |
| 2025-12-22 | -17.48 |
| 2025-12-19 | -16.93 |
| 2025-12-18 | -17.93 |
| 2025-12-17 | -17.66 |
| 2025-12-16 | -17.98 |
| 2025-12-15 | -18.29 |
| 2025-12-12 | -18.61 |
| 2025-12-11 | -19.20 |
| 2025-12-10 | -19.39 |
| 2025-12-09 | -19.57 |
| 2025-12-08 | -19.07 |
| 2025-12-05 | -18.98 |
| 2025-12-04 | -19.39 |
| 2025-12-03 | -19.25 |
| 2025-12-02 | -19.57 |
| 2025-12-01 | -19.34 |
| 2025-11-28 | -19.29 |
| 2025-11-26 | -19.29 |
| 2025-11-25 | -19.25 |
| 2025-11-24 | -18.66 |
| 2025-11-21 | -19.25 |
| 2025-11-20 | -19.43 |
| 2025-11-19 | -19.02 |
| 2025-11-18 | -18.38 |
| 2025-11-17 | -19.39 |
| 2025-11-14 | -18.79 |
| 2025-11-13 | -19.57 |
| 2025-11-12 | -20.75 |
| 2025-11-11 | -19.25 |
| 2025-11-10 | -19.70 |
| 2025-11-07 | -18.66 |
| 2025-11-06 | -16.29 |
| 2025-11-05 | -15.34 |
| 2025-11-04 | -15.79 |
| 2025-11-03 | -15.61 |
| 2025-10-31 | -14.84 |
| 2025-10-30 | -14.47 |
| 2025-10-29 | -14.47 |
| 2025-10-28 | -15.16 |
| 2025-10-27 | -15.29 |
| 2025-10-24 | -15.66 |
| 2025-10-23 | -14.25 |
| 2025-10-22 | -14.84 |
| 2025-10-21 | -15.06 |
| 2025-10-20 | -15.29 |
| 2025-10-17 | -14.34 |
| 2025-10-16 | -15.20 |
| 2025-10-15 | -15.20 |